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Increased spontaneous MeG signal 
diversity for psychoactive doses of 
ketamine, LsD and psilocybin
Michael M. schartner1, Robin L. Carhart-Harris2, Adam B. Barrett1, Anil K. seth1 & 
suresh D. Muthukumaraswamy3
What is the level of consciousness of the psychedelic state? empirically, measures of neural signal 
diversity such as entropy and Lempel-Ziv (LZ) complexity score higher for wakeful rest than for 
states with lower conscious level like propofol-induced anesthesia. Here we compute these measures 
for spontaneous magnetoencephalographic (MeG) signals from humans during altered states of 
consciousness induced by three psychedelic substances: psilocybin, ketamine and LsD. For all three, 
we ind reliably higher spontaneous signal diversity, even when controlling for spectral changes. This 
increase is most pronounced for the single-channel LZ complexity measure, and hence for temporal, as 
opposed to spatial, signal diversity. We also uncover selective correlations between changes in signal 
diversity and phenomenological reports of the intensity of psychedelic experience. This is the irst time 
that these measures have been applied to the psychedelic state and, crucially, that they have yielded 
values exceeding those of normal waking consciousness. These indings suggest that the sustained 
occurrence of psychedelic phenomenology constitutes an elevated level of consciousness - as measured 
by neural signal diversity.
Understanding the brain basis of consciousness remains one of the outstanding challenges in modern science. 
While rigorous deinitions are still mainly lacking, consciousness can be deined rather broadly as that which 
“vanishes every night when we fall into dreamless sleep” and returns the next morning when we wake up1. 
Equally, when we are conscious, our conscious experiences are populated by a variety of perceptions, thoughts, 
and feelings that collectively form an integrated conscious scene. hese observations lead to an intuitive distinc-
tion between conscious level (how conscious one is) and conscious content (what one is conscious of, when one is 
conscious). he large majority of recent neuroscientiic research into consciousness has treated these dimensions 
separately2–5. Investigations of conscious level typically contrast global changes in brain activity among diferent 
states including wakeful awareness, various sleep stages, and diferent forms of anaesthesia. Many of these studies 
attempt to isolate neural changes that accompany alterations of conscious level independently of changes in gen-
eral physiological arousal. Studies of conscious content have focused primarily on uncovering diferences in brain 
activity between closely matched conscious and unconscious perception, while conscious level is maintained 
constant6.
Recently, following early suggestions that increased conscious level may be related to an increased range of 
conscious contents3,7, there has been growing interest in characterising how conscious level and conscious con-
tent may relate2,5. One empirical approach to this question is to apply emerging measures of conscious level to 
experimental manipulations that primarily afect conscious content. Here, we capitalise on the profound efects 
on conscious phenomenology elicited by psychedelic compounds, speciically LSD, psilocybin, and subanesthetic 
doses of ketamine. hese drugs normally have profound and widespread efects on conscious experiences of 
self and world. More speciically, they appear to “broaden” the scope of conscious contents, vivifying imagina-
tion8 and positively modulating the lexibility of cognition9,10. At the same time, the states they induce are not 
accompanied by a global loss of consciousness or the marked changes in physiological arousal as seen in sleep or 
anaesthesia. hese observations raise the question of whether theoretically-grounded measures of conscious level 
would be changed in the psychedelic state.
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Empirical measures of conscious level have reached a new benchmark with the development of the pertur-
bational complexity index, PCI11. he PCI quantiies the diversity across channels and observations of the EEG 
response to a transcranial magnetic stimulation (TMS) pulse and has been shown to robustly index levels of 
consciousness6, ranging from anaesthesia induced by various substances11,12, sleep stages11 and graded disorders 
of consciousness such as (emergence from) the minimally conscious state11,13. Notably, all these comparisons 
resulted in lower PCI values compared to a baseline state of wakeful awareness.
One disadvantage of the PCI approach is that it requires brain stimulation, which limits its applicability and 
generalisability. A complementary approach is therefore to measure signal diversity of spontaneous neural activ-
ity recorded under various manipulations of conscious level. Following early studies of anaesthetics14–16 and nat-
ural sleep states17,18, we recently found reliable reductions in neural signal diversity with diminished conscious 
level across a range of measures and experimental manipulations, focusing on spontaneous electrophysiological 
recordings. hese measures include: versions of Lempel-Ziv complexity (LZc, LZs), which quantify the number 
of distinct patterns present in the data; amplitude coalition entropy (ACE), which relects the entropy over time 
of the constitution of the set of most active channels; and synchrony coalition entropy (SCE), which relects the 
entropy over time of the constitution of the sets of synchronous channels. hese measures of signal diversity 
robustly index levels of propofol sedation19 and sleep stages20,21 when applied to spontaneous electrophysiologi-
cal recordings. As with the PCI studies, these measures were reliably higher for conscious than for unconscious 
conditions.
Measures of entropy and Lempel-Ziv complexity both capture the diversity of a signal. In the limit of an 
ininitely long binary string, Lempel-Ziv complexity22 becomes directly proportional to the entropy of the process 
generating the string, provided the process is ergodic. Further, it can provide a good approximation to the entropy 
of a binary string if its length is of order of magnitude 1000 or greater23, a length easily obtainable for MEG/EEG 
data segments spanning just a few seconds. Note however, that a reordering of the components of a string can 
change the Lempel-Ziv complexity. For example, if all the 1 s are grouped together then the Lempel-Ziv complex-
ity goes to approximately zero. By contrast, reordering does not afect the entropy. he Lempel-Ziv complexity 
and entropy measures considered here (LZc, LZs, ACE, SCE) go beyond characterising a single binary string 
(except LZs), e.g. for the coalition entropy measures each component in the considered string is a subset of the 
set of observed channels. hus, the relations between these measures is more complicated. Indeed, these meas-
ures have been shown to diverge in their behaviour in certain scenarios19, such as when there is high correlation 
between channels. hus, it is valuable to consider the behaviour of these measures collectively, when character-
ising signal diversity.
Functional MRI-based measures of entropy have previously been found to be greater in the psychedelic state 
than in normal waking consciousness8,24–26 and this efect has been related, both theoretically8,24 and empiri-
cally8,26, to the phenomenal qualities of the psychedelic state. Given that Lempel-Ziv complexity can quantify 
the true entropy of certain stochastic processes more accurately than direct approximate entropy measures23, it is 
arguably more sensitive to signal diversity than entropy measures that have been applied previously to psychedelic 
data. Moreover, no such measures have previously been applied to data derived from EEG or MEG recordings 
of the psychedelic state. EEG/MEG data have far higher temporal resolution than fMRI and therefore are much 
better suited for signal diversity analyses. In addition, using Lempel-Ziv complexity allows analyses of the psyche-
delic state to be compared with similar analyses applied to more global changes in conscious level, as previously 
described19–21.
Here, we sought to test the hypothesis that three different psychedelic drugs (psilocybin, LSD and 
sub-anaesthetic ketamine), known to produce unusual altered states of consciousness, characterised by rich phe-
nomenal content, would yield scores of signal diversity exceeding those for normal waking consciousness. For 
parsimony, ketamine is referred to as a ‘psychedelic’, while acknowledging that its pharmacology and subjective 
efects are somewhat diferent to those of the ‘classic’ serotonergic psychedelics, such as LSD and psilocybin. We 
did this by re-analysing multidimensional spontaneous MEG recordings using our measures of spontaneous 
signal diversity. We compared signal diversity for two conditions: post-placebo and post-psychedelic drug. We 
further examined whether changes in measured signal diversity could be related to subjective phenomenological 
descriptions obtained following drug administration, in order to test whether these changes relected speciic 
aspects of the altered phenomenology of the psychedelic state, and to shed additional light on the complex rela-
tions linking conscious level and content.
Methods
overview. We re-analysed MEG recordings from healthy subjects with open eyes, ater taking a placebo and 
ater taking a psychedelic drug. he data come from three diferent experiments; in each, a diferent drug was 
administered intravenously to diferent participants: lysergic acid diethylamide (LSD)27, ketamine (KET)10 and 
psilocybin (PSIL)28. Ater artefact removal and source modelling (see following sections for details), we analysed 
2 sec segments of 90 source channels at 600 Hz: 5–7 min data for 15 participants for LSD, 6–10 min data for 19 
participants for KET and 2–5 min data for 14 participants for PSIL, each time comparing resting state MEG for 
the drug condition with a placebo condition.
ethics statement. All studies were approved by a UK National Health Service research ethics committee 
and participants gave informed consent. Experiments were performed in accordance with relevant guidelines 
and regulations.
participants and drug dose. For all three datasets, participant exclusion criteria have been previously 
described in detail (PSIL28, KET10, LSD27). Briely, participants were excluded if they were younger than 21, 
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pregnant, had personal or immediate family history of psychiatric disorder, sufered from substance dependence, 
had cardiovascular disease, sufered from claustrophobia, blood or needle phobia, had ever had a signiicant 
adverse response to a hallucinogenic drug, or if they had a medically signiicant condition rendering them unsuit-
able for the study. All participants had previous experience with a hallucinogenic drug but not within 6 weeks of 
the study (for LSD and PSIL only). For KET, participants were additionally excluded if they smoked, were female, 
or had a body mass index outside the range of 18–30 kg/m2.
LSD and PSIL were each administered intravenously at a ixed single dose of 75 µg and 2 mg, respectively, over 
the course of less than one minute. By contrast KET was administered with an initial bolus of 0.25 mg/kg delivered 
over one minute followed by maintenance infusion at a rate of 0.375 mg/h for forty minutes. PSIL and KET data 
were obtained immediately ater drug administration, whereas for LSD the data were obtained four hours ater 
drug administration due to LSD’s slow pharmacodynamics.
Data acquisition and preprocessing. Participants lay in a supine position for KET and LSD but were 
seated for PSIL. Pulse rates and blood oxygenation levels were continually monitored throughout the experiment 
via a probe over the let hand index inger. Whole-head MEG recordings were made using a CTF 275-channel 
radial gradiometer system sampled at 1200 Hz (0–300 Hz band-pass). An additional 29 reference channels 
were recorded for noise cancellation purposes and the primary sensors were analysed as synthetic third-order 
gradiometers. For LSD and KET, in addition to the MEG channels, ECG, horizontal and vertical participant 
electro-oculograms,  and electromyograms from the bilateral frontalis and temporal muscles were obtained and 
participant compliance was monitored via an eyetracking camera.
All MEG recordings were band-pass iltered (1–150 Hz), downsampled to 600 Hz and segmented into epochs 
of 2 sec length. Each epoch was then visually inspected, and those with gross artifacts (e.g. head movements, jaw 
clenches) were removed from the analysis. An automated algorithm was used to remove further epochs contam-
inated with muscle artefacts. In this algorithm, a set of 30 gradiometer sensors were predeined at the edge of 
the MEG dewar (vacuum lask), as these are most likely to be contaminated by muscle artefacts. Using Hanning 
windowed fourier transformations, the mean spectral power for these sensors in the 105–145 Hz frequency band 
for each epoch was calculated. If the resulting power averaged across these sensors exceeded 10 fT2, then that 
epoch was eliminated from subsequent analysis. On the remaining epochs, independent component analysis 
(ICA) was performed, as implemented in Fieldtrip/EEGLAB, to identify and remove ocular, muscle and cardiac 
artifacts from the data. For LSD and KET, any components that showed a correlation (r > 0.1) in the time domain 
with the EOG/EMG electrodes were automatically removed, whereas these were identiied manually for the PSIL 
data. Likewise, any components that showed correlations (r > 0.1) with similarly iltered EOG/EMG channels 
ater being bandpass iltered in the range 105–145 Hz were removed. Visual inspection was also used to remove 
artifact components.
Source modelling of the data was performed using the ieldtrip toolbox29. For each participant, individual 
forward models were generated from their individual structural MRI scan30. In order to reduce the data, an 
atlas-based beamformer approach was used31. Broadband virtual sensor time-series were constructed using a 
linearly constrained minimum variance beamformer32 at 90 cortical and subcortical seed locations as speciied in 
the automated anatomical labelling atlas33.
Prior to computing signal diversity measures, the data were further low-pass iltered with cut-of at 30 Hz to 
assure that possible muscle artefacts were excluded. Some residual muscle artefacts were seen in the LSD dataset27 
and so the conservative approach was to apply the 30 Hz low-pass ilter to all datasets.
Measures. Lempel-Ziv complexity. (LZc, LZs, LZcN, LZsN); We computed Lempel-Ziv complexity follow-
ing our previous studies19,21. As schematically shown in Fig. 1, the instantaneous amplitude (obtained via Hilbert 
transform) of each source channel is binarised using its mean over observations as a threshold. I.e. the continuous 
signal of each source channel is transformed into a string of 1200 binary digits (for our case of 2 sec segments at 
600 Hz sampling rate), resulting in a matrix with binary entries with a row for each channel and a column for 
each observation. To assess the signal diversity across all channels and observations, this binarised data matrix 
is concatenated observation-by-observation into one binary string. hen the encoding step of the Lempel-Ziv 
1978 (LZ78) compression algorithm (implemented by adapting open source code) is applied to this binary string. 
he LZ78 algorithm divides the string into non-overlapping and unique binary substrings. he more diverse the 
binary string, the more substrings will be  listed (a sequence containing only zeros or only ones would lead to the 
minimal number of substrings being obtained). he total number of these substrings is what we call Lempel-Ziv 
complexity LZc.
Given the observation-by-observation concatenation of the binarised data matrix, LZc captures temporal 
signal diversity of single channels as well as spatial signal diversity across channels. In order to assess temporal 
signal diversity only, we further applied this procedure to single source channels independently, and we denote 
the resulting single channel Lempel-Ziv complexity by LZs. I.e. LZs quantiies the temporal signal diversity of 
single channels, with a high score for a uniformly random binary string and a low score for a string of zeros only. 
We normalize LZc (also LZs) by dividing the raw value by the value obtained for the same binary input 
sequence randomly shuled. Since the value of LZc (also LZs) for a binary sequence of ixed length is maximal if 
the sequence is entirely random, the normalized values indicate the level of signal diversity on a scale from 0 to 1.
In order to test if changes in the diversity measures in the drug vs placebo contrast can be explained away by 
previously characterised changes in the overall power spectrum, we employed the following control procedure 
(as in ref. 19). We generate surrogate time series through phase-shuling of the data, maximising signal diversity 
as measured by non-normalised LZs (analogously non-normalised LZc) under the constraint of preserving the 
spectral power proile of the data. If the observed diference in non-normalised LZs between drug and placebo 
was completely preserved in the equivalent contrast for the surrogate data, we would conclude that the observed 
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diference is entirely due to changes of the power spectrum and not due to changes in signal diversity beyond 
spectral changes. If, on the other hand, the diference was completely absent for the surrogate data, we would 
conclude that the observed diference in non-normalised LZs was entirely due to changes in signal diversity that 
were not expected from the spectral power proiles.
We apply this rationale by comparing the ratio of diversity scores for data and surrogate data as follows. 
Assume that D1 is the LZs (LZc) score for the placebo condition (state 1) and D2 that for the drug condition (state 
2). Assume D1 < D2 and let N1 be the average LZs score of the phase-shuled data of state 1 (analogously N2 for 
state 2). If D1/N1 > D2/N2, then it must be that N1 < N2. hus, this outcome implies that the diference in signal 
diversity between the states, D1 < D2, can be entirely explained by the diference in power spectra alone, as the 
maximal signal diversity given the spectral power proile of state 1 is much smaller than that of state 2. Conversely, 
without such reversal of results we can exclude that the observed signal diversity changes are entirely due to 
changes in the spectral power proile, i.e. some of the diference in diversity between the states must be due to the 
speciic properties of the data captured by LZs (analogously LZc).
For a given participant and condition we thus computed LZc (LZs) for all 2 sec data segments. hen we 
phase-randomised each channel’s time series for each 2 sec segment and then recalculated LZc (LZs). Phase ran-
domisation was performed by irst applying a discrete Fourier transform, then randomising phases of the fre-
quencies while keeping their amplitudes ixed, and then applying the inverse Fourier transform (i.e. only the 
relative temporal positions [phases] of the Fourier sinusoids, whose superposition equals the signal, are randomly 
changed). For a given participant and condition, measuring the average diversity across many phase-shuled data 
segments gives the highest signal diversity possible for the spectral power proile for that participant in that con-
dition, i.e. N1. We denote Lempel Ziv complexity measures normalised by average scores for phase-randomised 
data (D1/N1) as LZcN (LZsN).
Coalition entropy. (ACE, SCE, ACEN, SCEN); Synchrony coalition entropy (SCE) is a measure of the entropy 
over time of the constitution of the set of channels that are in synchrony, see ref. 21 for details and Fig. 1 for a 
schematic. SCE normalized by its score for phase-randomised data is denoted as SCEN.
Amplitude coalition entropy (ACE) is deined as in ref. 21 as the entropy (over time) of the constitution of 
the set (coalition) of channels that are ‘active’, given the binarization scheme described above for LZc for dein-
ing ‘active’/‘inactive’ channels. As for LZc, we normalise ACE by its value for a random shuling of the data. We 
further consider renormalisation by the mean value obtained from phase-randomised surrogate data (ACEN), as 
described above for LZc.
Figure 1. Schematic of the computation of LZc and SCE. LZc: (a) xi is the activity of the i
th channel and ai is 
the (Hilbert) amplitude of xi. (b) bi is ai binarised, using the mean activity of ai as the binarisation threshold. 
(c) Ater binarisation of all n signals, (d) the multidimensional time series are concatenated observation-by-
observation into one binary sequence k and then (e) repeated patterns are searched and listed into a dictionary 
of binary words via a Lempel-Ziv algorithm. Lempel-Ziv complexity LZc is proportional to the size of this 
dictionary. SCE: (a) Two time series. (b) he analytic signals of these two, which are complex signals with the 
real part being the original signal and the imaginary part being the Hilbert transform of the original signal. (c) 
A binary synchrony time series is created for this pair of signals; a 1 indicates that the phases of the complex 
values of the analytic signals are similar (diference of less than 0.8 modulo 2pi). (d) Such time series are 
obtained to represent each channel’s synchrony with seed channel i. e) SCE(i) is the entropy over observations in 
the resulting data matrix. he overall SCE is then the mean value of SCE(i) across choices of seed channel i.
www.nature.com/scientificreports/
5Scientific RepoRts | 7:46421 | DOI: 10.1038/srep46421
Note that ACE and SCE are only deined for multidimensional time series, capturing signal diversity over 
channels and time.
Normalized spectral power and phase coherence (PC). he behaviour of the signal diversity measures is compared 
to that of normalized spectral power and phase coherence. We deined power bands as: δ = 1–4 Hz, θ = 4–8 Hz, 
α = 8–15 Hz, β = 15–30 Hz and γ = 30–70 Hz. For the computation of spectral power, the data was not low-pass 
iltered at 30 Hz, as was the case prior to the computation of the signal diversity measures. he power of a spectral 
band was computed using Welch’s method34 for each 2 sec segment of each of the 90 sources, normalised by the 
sum of the power of all 5 bands, then averaged across sources and trials per subject.
As a measure of overall synchrony we use the mean phase coherence (PC) across all pairs of channels. Let 
=
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with T being the length of the segment (1200 observations = 2 sec) and N = 90 the number of sources. Reported 
PC scores are averages across trials. Scores of PC lie between 0 and 1, with 1 indicating perfect synchrony and 0 
indicating no synchrony at all (phase diferences uniformly randomly distributed).
Questionnaire scores. Across the three experiments, diferent questionnaires were employed for partic-
ipants to retrospectively evaluate their psychedelic experience. Here, we analyse a subset of the questionnaire 
items that were common across all three experiments, i.e. for PSIL, KET and LSD:
strange: “hings looked strange”.
geom: “I saw geometric patterns”.
vivid: “My imagination was extremely vivid”.
time: “My perception of time was distorted”.
space: “My sense of size and space was distorted”.
ego: “I experienced a disintegration of my ‘self ’ or ‘ego’”.
muddle: “My thinking was muddled”.
merge: “I experienced a sense of merging with my surroundings”.
control: “I feared losing control of my mind”.
spirit: “he experience had a spiritual or mystical quality”.
peace: “I felt a profound inner peace”.
loat: “I felt like I was loating”.
past: “I saw events from my past”.
sounds: “Sounds inluenced things I saw”.
For all three experiments subjective questionnaires were completed retrospectively on the day of the experi-
ments ater most drug efects had subsided, asking participants to recall experiences they had at the time of peak 
drug efects. For KET and PSIL this was typically an hour ater drug delivery had ceased but was approximately 
8 hours ater LSD due to its relatively prolonged pharmacodynamic proile. MEG scans were taken for KET and 
PSIL at peak drug efects, whereas for LSD, MEG scans were typically taken one to two hours post peak efects, 
i.e. immediately post drug administration for KET and PSIL, and around four hours post drug administration for 
LSD. Participants answered each question using a visual analogue scale format with a bottom anchor of “no, not 
more than usually” and a top anchor of “yes, much more than usually”. In addition, we consider the mean score 
over all these questions as an index of overall intensity of the psychedelic state. We call this index “total”.
Further, we obtained a single subjective rating of the overall drug-efect intensity, acquired while participants 
were inside the MEG scanner. his rating is for each drug denoted as “InScanner” and was obtained for LSD27 and 
PSIL28 by asking participants “please rate the intensity of the drug efects during the last scan” and for KET10 by 
asking “please rate your subjective high on a scale between 0 and 40”, using a two-digit button box.
statistics. Analyses were performed using non-overlapping segments of length 2 sec for a total length 
between 2 min and 10 min of MEG recording per participant and state. For each segment, the signal diversity 
measures ACE, SCE and LZc were computed for 30 random picks of 10 channels, and the mean across these 30 
scores was considered the score for the segment. We chose 10 channels since in our previous study19 this was 
the smallest channel number for which we still found a robust decrease of ACE, SCE and LZc for EEG signals in 
propofol-anaesthesia. To verify that the results obtained were not dependent on the particular random channel 
selection, we performed a re-run of the complete analysis and indeed obtained almost identical results. For LZs, 
the mean across all 90 channels was set as the score for the segment. he mean and standard error of the diversity 
measures’ scores were computed across segments. At the single participant level, the efect size of diferences 
between states was measured using Cohen’s d35. We call an efect size high if d > 0.7. For group level comparisons, 
a two-sided t-test was applied, with Bonferroni correction (by the number of measures) where indicated.
Computation of correlation between measures. We computed the Pearson correlation across partic-
ipants for the score diferences of 14 measures (measure(drug)-measure(placebo)): he diversity measures ACE, 
LZs, LZc and SCE, their phase-randomised renormalised versions ACEN, LZcN, LZsN, SCEN, phase coherence 
and normalised spectral power in the delta, theta, alpha, beta and gamma band. For a given participant, trial and 
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measure, we subtracted this measure’s score for the placebo condition from that of the drug condition to obtain 
a score diference for one trial. he average value across trials was used for this measure and participant. he 
Pearson correlation r is then computed for such scores for two measures across all participants for a given drug.
Results
Increased spontaneous signal diversity for all three drugs. Our main question was whether spa-
tio-temporal signal diversity of MEG recordings increases in the psychedelic state, so we computed LZs, LZc, 
ACE and SCE for all three drug and placebo conditions and compared their scores on the participant and group 
level. To exclude the possibility that any observed changes could be attributed solely to changes in overall spectral 
proile, we also computed these diversity measures normalised by their scores for phase-shuled data, denoted by 
subscript “N”: ACEN, LZcN, LZsN and SCEN.
Across all drugs and all diversity measures (except SCEN), we found increased signal diversity in the psyche-
delic state as compared to the placebo condition, with most comparisons reaching statistical signiicance, see 
Table 1. he most consistent increase for all three drugs when compared to placebo, was for LZsN, with higher 
average scores for 86%, 100% and 93% of participants for PSIL, KET and LSD respectively (Fig. 2b), resulting 
in higher LZsN at the group level with p < 0.05 (Bonferroni corrected) for KET and LSD. Notably, the two par-
ticipants for whom a higher score for PSIL was not observed also had the lowest average score across all sub-
jective ratings for the intensity of the psychedelic experience (“total”) among all participants (see also Sections 
“Questionnaire scores” and “Neurophenomenological correlations”). Considering other measures, notably ACE, 
LZc and LZs, all scored on average signiicantly higher for both KET and LSD than placebo (p < 0.05, Bonferroni 
corrected). he diferences for PSIL versus placebo didn’t reach signiicance for any of the measures, although a 
higher value for PSIL was observed for most subjects. Figure 2a shows the results for the measures ACEN, LZcN, 
LZsN at the group level. he fact that single channel Lempel-Ziv complexity, as captured by LZsN, exhibited the 
most strongly signiicant increase of the diversity measures suggests that increased temporal signal diversity is a 
stronger hallmark of the psychedelic state than spatial signal diversity.
hat in addition to ACE, LZc and LZs also the phase-randomisation renormalised measures ACEN, LZcN and 
LZsN all exhibit higher values for the clear majority of subjects for each of the drugs in comparison to placebo 
(and signiicantly so in several cases) illustrates that there is a generalised increase in signal diversity in the psy-
chedelic states beyond that expected from spectral changes (see “Methods” for details of this control). However, 
as efect sizes at the single participant level were generally lower for the phase-randomisation renormalised meas-
ures, there was some increase in signal diversity deriving from spectral changes (Table 1).
For comparison with the signal diversity measures, we computed phase coherence and normalized spectral 
power for various frequency bands, for all three drugs and the placebo condition. All 90 sources were used to 
compute these measures (Section “Normalized spectral power and phase coherence (PC)”). Strongest changes in 
the average power spectrum were seen for the alpha band (8–15 Hz), where a decrease in power was observed for 
all drugs relative to placebo, with large efect sizes for the majority of participants (in line with refs 10, 27, 28), see 
Table 1. For phase coherence (PC), we found no signiicant diference between any drug and placebo.
Measure
PSIL (n = 14) KET (n = 19) LSD (n = 15)
% t p efect size % % t p efect size % % t p efect size %
ACE ↑ 86 1.4 0.185 43 50 7 ↑ 95 3.9 0.000 68 32 0 ↑ 93 4.3 0.000 87 13 0
ACEN ↑ 71 0.8 0.428 0 100 0 ↑ 89 2.8 0.008 0 100 0 ↑ 73 1.7 0.093 0 100 0
LZc ↑ 79 1.5 0.154 14 86 0 ↑ 100 3.7 0.001 37 63 0 ↑ 87 3.4 0.002 40 60 0
LZcN ↑ 86 1.3 0.197 0 100 0 ↑ 100 3.4 0.002 0 100 0 ↑ 80 2.5 0.018 0 100 0
LZs ↑ 86 1.5 0.134 57 36 7 ↑ 89 3.4 0.002 74 26 0 ↑ 100 4.9 0.000 93 7 0
LZsN ↑ 86 1.4 0.173 0 100 0 ↑ 100 3.5 0.001 0 100 0 ↑ 93 4.8 0.000 0 100 0
SCE ↑ 71 0.3 0.767 36 50 14 ↑ 89 2.4 0.021 68 26 5 ↑ 60 1.1 0.293 40 40 20
SCEN ↓ 64 0.9 0.370 0 100 0 ↑ 53 0.0 0.971 0 95 5 ↓ 73 2.4 0.022 0 100 0
PC ↑ 64 0.7 0.509 29 71 0 ↓ 74 0.9 0.365 47 47 5 ↑ 67 1.1 0.300 47 33 20
δ ↑ 71 0.9 0.363 14 79 7 ↓ 74 2.1 0.043 47 53 0 ↓ 73 1.4 0.184 40 53 7
θ ↑ 64 0.5 0.636 29 57 14 ↑ 68 1.4 0.159 53 37 11 ↓ 80 2.2 0.038 73 27 0
α ↓ 86 2.2 0.041 64 29 7 ↓ 95 3.2 0.003 79 16 5 ↓ 93 3.3 0.003 80 20 0
β ↓ 86 0.7 0.519 36 57 7 ↓ 79 2.0 0.057 42 53 5 ↓ 67 1.0 0.339 53 33 13
Table 1.  Characterisation of the changes in signal diversity, phase coherence, and power spectrum in 
the psychedelic state. For each measure and drug, the percentage of participants for which the measure was 
higher (indicated by up-arrow), or lower (indicated by down-arrow) in the drug condition than placebo is 
given, followed by the t-statistic and uncorrected p-value of a two-sided t-test across participants for conditions 
placebo and drug. he number triplet in column “efect size %” lists for which percentage of participants the 
measure’s score changed in the arrow-indicated direction with high efect size (let digit), in the opposite 
direction with high efect size (right digit) or in either direction but with low efect size (middle digit). Efect 
size is said to be high if Cohen’s d was greater than 0.7. he font of a p-value entry is in italics if the p-value was 
below 0.05 (but not the Bonferroni corrected p-value). If the Bonferroni corrected p-value was below 0.05, the 
entry is in boldface.
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To examine whether changes in signal diversity showed any anatomical localisation, we compared local signal 
diversity changes across drugs, using phase-randomisation renormalised single-channel Lempel-Ziv complexity 
LZsN. For a given drug, participant and source channel, ∆ LZsN = LZsN(drug) − LZsN(placebo) was obtained as 
an average across all 2 sec data segments. For each of the 90 sources, the t-statistic obtained for the ∆ LZsN scores 
across participants was mapped in color onto a standard MNI brain, shown in Fig. 3 (wherever signiicant at 
the p < 0.05 level, false discovery rate [FDR] corrected). For all three drugs, substantial increases in LZsN can be 
seen in occipital-parietal areas, despite diferences in pharmacological target region and psychological efects for 
each drug. he regions with signiicant changes for PSIL also had signiicant changes for KET and LSD, and are 
thus the regions with signiicant changes across all drugs. hese spatial distributions, with maximal locations 
in occipital and parietal areas are consistent with the localisation of alpha-band changes that were previously 
reported10,27,28.
In summary, we found a clear increase in signal diversity for all three psychedelic agents at the group level, 
with efects being strongest for KET. hese increases went beyond those expected from the changes to the fre-
quency spectrum. We further conirm a consistent decrease in normalised alpha power for all three drugs, in line 
with previous analyses of the data10,27,28.
Correlations between neurophysiological measures. To test whether the various measures (both sig-
nal diversity measures and others) were relecting distinct features of the data, we computed correlations between 
Figure 2. Increased spontaneous signal diversity for PSIL, KET and LSD. (a) Mean scores across participants 
for the signal diversity measures LZsN, LZcN and ACEN are higher for each of the three drug conditions (white 
discs) than for the corresponding placebo conditions (black discs). A solid line across conditions indicates 
p < 0.001 and a dotted line 0.001 < p < 0.05, uncorrected, obtained from a two-sided t-test. (b) Diference in 
single channel Lempel-Ziv complexity, LZsN, between respectively PSIL, KET, LSD and placebo at the single 
participant level. he error bars indicate standard error across trials.
www.nature.com/scientificreports/
8Scientific RepoRts | 7:46421 | DOI: 10.1038/srep46421
the changes in these measures, across participants, for each comparison between drug and placebo. he Pearson 
correlation r is computed for two measures across all participants for a given drug (see “Methods” for details) and 
Figure 3. t-statistics across participants of ∆LZsN per source channel. Group level changes in single channel 
Lempel-Ziv complexity, ∆ LZsN, are indicated by the t-statistic for each of the 90 source channels and 3 drugs 
(where signiicant at the p < 0.05 level, FDR corrected). For all three drugs, an increase in LZsN can be seen in 
occipital-parietal areas. Image created using BrainNet viewer55.
Figure 4. Correlations across measures and questionnaire answers. (a) For each drug, a matrix indicates 
in colour the Pearson correlation, r, of the score diference between drug and placebo condition (averaged 
across trials) of each measure pair across participants. he upper triangular entries and entries with |r| < 0.5 
are omitted (and set white) to highlight strong correlations only. hese correlations should be considered 
somewhat exploratory and are not controlled for multiple comparisons as each experiment had a limited sample 
size. Across drugs, signal diversity measures show high correlation with each other, yet inconsistently, as they 
capture diferent lavours of signal diversity. (b) Correlations between the changes in the measures ACEN, LZcN 
and LZsN and the questionnaire scores (same scale as above). No consistent correlation across drugs was found 
for any combination of the measure’s scores and scores for a particular question. (c) he changes in subjective 
ratings under each drug condition are shown as averages with standard error bars across subjects. he average of 
all changes across these 14 questions (except “InScanner”) is denoted as “total” and shown normalised by factor 
20 in order to it the scale. No consistent diferences are apparent across drugs.
www.nature.com/scientificreports/
9Scientific RepoRts | 7:46421 | DOI: 10.1038/srep46421
indicated in colour in Fig. 4 if r > 0.5, in order to highlight moderate and stronger correlations only. For clarity, 
the upper triangular portion of the symmetric correlation matrices is hidden.
We found strong correlations across most diversity measures for all three drugs. Slight inconsistencies in these 
correlations across drugs show that the measures capture not identical signal features, in line with their varying 
behaviour as listed in Table 1 and their distinct mathematical deinitions. Most diversity measures show stronger 
correlations with normalised spectral power bands when compared to their versions normalised by their scores 
for phase-randomised data (indicated by subscript N), verifying that the phase-shuling normalisation indeed 
reduced the measures’ sensitivity to spectral changes, as intended. Phase coherence, PC, did not correlate strongly 
with the diversity measures; in particular, correlations between PC and LZsN were weak. (See Fig. S1 for full cor-
relation matrix).
Neurophenomenological correlations. Having established that signal diversity measures increase in 
the psychedelic state, we next asked whether these increases were related to subjective measures. We therefore 
computed the Pearson correlation for all combinations of the measures LZsN, LZcN and ACEN with the scores 
of 14 subjective ratings of the participants’ psychedelic experience acquired ater the drug efects had faded, i.e. 
post-experiment, and one rating obtained in the MEG scanner (“InScanner”) at a time when the drug efects were 
still strong, as deined in Section “Questionnaire scores”. he results are shown in Fig. 4b. (See Fig. S1 for correla-
tions with the entire list of measures).
Supporting a relation between phenomenology and signal diversity, the measure LZsN, which showed the 
strongest overall response to the psychedelic state across drugs, correlates substantially (r > 0.5) with the total 
score for all questions (“total”) for PSIL and KET. Recall that the two participants with the lowest total score 
across all questions for PSIL were the two outlying participants for ∆ LZsN as shown in Fig. 2b (i.e. these partici-
pants did not show an increase in LZsN under PSIL). hese observations support the notion that LZsN correlates 
with the intensity of the psychedelic experience.
In addition, strong correlations were found between all 3 signal diversity measures and the total score across 
questions for KET. For this drug, all three diversity measures also showed further strong correlations with spe-
ciic phenomenological dimensions, in particular ego dissolution and vivid imagination. However, for LSD only 
“InScanner” correlated strongly with LZsN while for PSIL, LZsN correlated strongly with scores for only two of the 
individual questions in addition to the total score. he absence of strong correlations between post-experiment 
subjective ratings and signal diversity for LSD may be due to the fact that in the LSD study, the questions were 
asked with reference to the period when subjective efects were maximal and not for the time in the MEG scanner 
(2 h post drug efect peak), unlike for KET and PSIL, where the MEG scan took place close to drug efect peak. 
However, no strong neurophenomenological correlations involving “InScanner” ratings were found for PSIL and 
KET. For certain phenomenological dimensions, such as “space” and “ego” which correlated with LZsN for PSIL, 
the subjective ratings were weaker for LSD in comparison to the other drugs, although this was not the case for 
all dimensions and, importantly, for the scores of “total” diference in phenomenology, for LSD lay above that for 
KET and below that for PSIL, suggesting that the overall intensity of the psychedelic experience induced by LSD 
was comparable to the other drugs, see Fig. 4c.
In sum, subjective ratings of the psychedelic experience correlate most strongly with spontaneous signal diver-
sity for KET, and while some strong correlations exist also for PSIL, the only strong neurophenomenological 
correlation observed for LSD involved “InScanner” ratings. he total score across all questions, being an index 
of the overall intensity of the psychedelic experience, correlates strongly with LZsN for PSIL and KET. Given the 
constraints on the acquisition of subjective reports, these indings tentatively support a relationship between 
psychedelic phenomenology and neural signal diversity as discussed below.
Discussion
We have demonstrated, for the irst time, that measures of neural signal diversity that are known to be sensitive to 
conscious level, are also sensitive to the changes in brain dynamics associated with the psychedelic state. We found 
that the psychedelic state induces increased brain-wide signal diversity as compared to placebo, across a range 
of measures and three diferent psychedelic compounds. he measures LZc, LZcN, LZs, LZsN, ACE and ACEN all 
scored higher at the group level for the drugs PSIL, KET and LSD, with strongly signiicant increases, consistent 
across subjects, seen for ACE, LZc, LZs and LZsN for KET and LSD. Importantly, by utilising phase-shuled sur-
rogate data, we excluded the possibility that the observed increases in signal diversity could be explained away by 
changes in the spectral proile induced by the drugs. Together, these indings constitute a new neural correlate of 
the psychedelic state that may have important broader implications for our understanding of the neural correlates 
of consciousness.
Despite the difering pharmacological mechanism of action of KET, LSD and PSIL, we observed a clear sim-
ilarity in the cortical localisation of changes in signal diversity measures - with relatively overlapping spatial dis-
tributions centered over occipital and parietal cortices. hese areas are strikingly similar to the locations of alpha 
power decreases that we have previously reported10,27,28, yet spectral changes alone do not account for changes in 
signal diversity as our “phase-randomisation” control showed. he primary psychedelic efects of LSD and PSIL 
are thought to be mediated via 5HT2A receptors36,37, which although distributed throughout the neocortex, have 
somewhat higher levels in occipital-parietal areas38,39. Conversely, KET’s primary mechanism of action is as an 
NMDA antagonist whose receptors are located quite ubiquitously across the cerebral cortex as well as subcor-
tically40,41. One could speculate that some of the shared phenomenological and electrophysiological efects of 
these drugs may be mediated by the known interactions between 5HT2A receptors and NMDA receptors42,43. 
Alternatively, 5HT2A receptor agonism and NMDA receptor antagonism may have similar efects on the activity 
of cortical cell populations44,45. his could account for the localised and overlapping areas of both signal diver-
sity and decreased alpha power that we have observed with all three drugs. However, the non-NMDA receptor 
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efects of KET cannot be discounted, in particular its interactions with opioid receptors and HCN channels46,47. 
Alternatively, it may simply be that MEG/EEG is well tuned to measure changes in these cortical areas due to local 
synchronisation properties of the underlying circuits in these areas.
Neural correlates of consciousness are particularly valuable when they can be mapped to phenomenological 
properties48,49. For KET, strong correlations across participants were found between scores of LZcN, LZsN and 
ACEN and speciic subjective ratings of the psychedelic experience, in particular for ego-dissolution and vividness 
of the experience, as well as the total score across all questions - relecting the overall intensity of the psychedelic 
experience. For PSIL, LZsN showed strong correlation with three questions, including the total “intensity” score, 
while for LSD, strong correlations were only found between signal diversity and the subjective ratings acquired 
in the scanner but not for ratings acquired at a time when the drug efects had faded. he weaker correlations 
found for LSD are likely to be due to the fact that participants were asked to rate their experience during peak 
drug efects, which was 2 h prior to the MEG scan, while for KET and PSIL the MEG scan took place when drug 
efects were at peak. Nevertheless, for the scores of “total” diference in phenomenology, LSD lay above KET and 
below PSIL, suggesting that the overall intensity of the psychedelic experience induced by LSD was not lower than 
for the other drugs.
While we10,27,28 and others50 have used the methodological approach of correlating subjective states with elec-
trophysiological measures across participants, it should be noted that this is an imperfect approach. In particular, 
the ratings of any individual are heavily inluenced by their individual biases and histories - each participant has 
their own yardstick for evaluating the strength of an experience. Further, the retrospective nature of the ratings 
relies on recall of the experience as a single entity and does not capture the dynamic, periodic features of the 
psychedelic experience. Future experiments which seek to capture temporal variation in experience through 
use of multiple probe items, experience sampling methods or perhaps even by spontaneous self-report, and ret-
rospective coding, may help to more tightly tie neurophysiological measures such as those we have used here to 
subjective experiences.
Correlations of perturbational and spontaneous signal diversity with conscious states support integrated 
information and complexity theories of consciousness that emphasise diversity of phenomenology as a key prop-
erty of consciousness that must be relected in its neural correlates1,48,51–53. Perturbational11,12 and - with weaker 
speciicity and sensitivity - spontaneous signal diversity measures capture types of neural signal diversity - across 
broadly distributed brain regions - that correlate with changes in conscious level across a broad range of states. 
Typically, research has focused on manipulations or pathologies involving a diminution of the overall level of con-
sciousness from a baseline of healthy conscious wakeful rest19,21. Pragmatically, these results suggest an operation-
ally useful one-dimensional scale for level of consciousness, with wakeful rest and REM sleep at the top and coma 
and propofol-induced general aneasthesia at the bottom. Our indings of increased spontaneous signal diversity 
for KET, PSIL and LSD presented here, represent the irst observations of an increase in theoretically-motivated 
measures of conscious level with respect to the baseline of wakeful rest, on such a one-dimensional scale. hese 
results broaden the scope of application of signal diversity measures relevant to conscious level, showing that the 
one-dimensional scale extends in both directions from the baseline state. While it may be tempting to describe 
the psychedelic state as a “higher” state or level of consciousness on the basis of our indings, any such description 
needs to be cautiously interpreted and properly qualiied.
he measures applied in this paper focus on signal diversity, rather than the simultaneous existence of inte-
gration and diferentiation (or integrated information) that are emphasised within complexity and integrated 
information theories of consciousness48. Our diversity measures are attractive because of simplicity, practical 
applicability, and consistency with both complexity-based48 and entropy-based8 theories about consciousness, 
providing a quantitatively useful mapping between neural signal dynamics and phenomenology.
Our indings of reliable changes in signal diversity in the psychedelic state suggest that further research could 
usefully consider less common alterations of consciousness, for example manic, dreamlike, delirious conditions. 
In these conditions, as in the psychedelic state, conscious scenes may be “richer”, or more “expansive” or “diverse” 
than normal.
Our results provide an example of how quantitative measures of neural dynamics can bridge the gap between 
studies of conscious content and conscious level and are in line with the intuitive suggestion that increases in 
conscious level correspond to increases in the range of possible conscious contents2,3,8. Recently, eforts to inesse 
the relationship between level and content have been made in the context of integrated information theory54 and 
in multidimensional descriptions of conscious level2. Interestingly, Bayne et al. suggest a multidimensional clas-
siication of conscious levels, with one dimension being the depth of context an observer grasps on average: for 
example whether only the colour of an object is perceived, or whether its purpose is also perceived. Distinctions 
like this may be useful in characterising the phenomenology of the psychedelic state. Further research into the 
relation between phenomenology and the detailed expression of measures of complexity and diversity at local and 
global levels will help reine and constrain these emerging ideas.
In sum, we found increased global neural signal diversity for the psychedelic state induced by KET, PSIL 
and LSD, suggesting the psychedelic state lies above conscious states such as wakeful rest and REM sleep on a 
one-dimensional scale deined by neural signal diversity. Future studies should assess the extent to which entropy 
and complexity based measures of signal diversity capture and confer the fundamental property of “richness” of 
conscious states, not only in the psychedelic condition but in conscious states more generally.
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